DA

Daluram Agrawal

Active Director Director DIN 00293428
DIN 00293428 First appointment Sep 1988 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Sep 1988
Shareholding value Locked Premium profile

About Daluram Agrawal

Daluram Agrawal has 37 years in corporate governance. Holds Director role. Currently with 1 company, including Hi-Tech Drugs Limited. Engaged in Technology. Contributes to corporate operations.

DIN 00293428
Primary Designation Director
First Appointment 06 Sep 1988
Oldest Company Age 37 yrs

Current companies

Company Designation Appointment Founded Status
Hi-Tech Drugs Limited U24239MP1988PLC004749
Director 06 Sep 1988 1988 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hi-Tech Drugs Limited
Premium access

Shareholding and investment profile for Daluram Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daluram Agrawal

Daluram Agrawal has 37 years in corporate governance. Holds Director role. Currently with 1 company, including Hi-Tech Drugs Limited. Engaged in Technology. Contributes to corporate operations.

Daluram Agrawal is associated with 1 company as Director.

Daluram Agrawal has expertise in Technology.

Daluram Agrawal has 37 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available